Clin Mol Hepatol.  2021 Oct;27(4):515-523. 10.3350/cmh.2021.0293.

Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline

Affiliations
  • 1Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Korea
  • 2Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Korea
  • 3Department of Gastroenterology, Ajou University School of Medicine, Suwon, Korea
  • 4Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Seoul, Korea
  • 5Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea

Keyword

SARS-CoV-2; COVID-19; Hepatocellular carcinoma; Liver cirrhosis; Hepatitis
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr